Solstein Capital’s Clorox CLX Stock Holding History

Solstein Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5	Closed	-$600	–	462
2025 Q2	$600	Buy	+5	New	+$667	﹤0.01%	477
2020 Q2	–	Sell	-7	Closed	-$1K	–	228
2020 Q1	$1K	Buy	+7	New	+$1.16K	﹤0.01%	241

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Solstein Capital's CLX Position: Q3 2025 in Review

Solstein Capital sold out of Clorox (CLX) in Q3 2025, closing a stake of 5 shares — an estimated $600 sold.

Solstein Capital first reported a position in CLX in Q1 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2020. 1,094 funds tracked by Wall St. Rank hold CLX as of Q3 2025.

Solstein Capital reported no remaining Clorox position as of Q3 2025 after selling out during the quarter.
Solstein Capital sold 5 Clorox shares in Q3 2025, an estimated $600.
Solstein Capital first reported a position in Clorox in Q1 2020 and held it in 2 quarters.
Solstein Capital's Clorox position peaked at $1K in Q1 2020.
1,094 funds tracked by Wall St. Rank held Clorox as of Q3 2025.

Based on Solstein Capital's 13F filing for Q3 2025, filed 12 Nov 2025.